SARS-CoV-2 infection: diagnostic testing results occasionally require special attention

Elisabetta Riva; Pier Paolo Sainaghi; Ombretta Turriziani; Guido Antonelli; Giuseppe Patti

doi:10.1080/22221751.2020.1814165

SARS-CoV-2 infection: diagnostic testing results occasionally require special attention

Elisabetta Riva
, Pier Paolo Sainaghi
, Ombretta Turriziani
, Guido Antonelli
, Giuseppe Patti

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Lettera › peer review

Abstract

The case refers to a 51-year-old symptomatic man with a new SARS-CoV-2 RNA positive nasopharyngeal swab after two negative ones and the lack of significant development of antibody response measured by different diagnostic serological test. Our case underlines that a discrepancy between clinical course of SARS-CoV-2 infection and results from diagnostic tests may exist. This concept is rapidly emerging and supports the need for a deep knowledge of available and “in development” tests for a correct interpretation of their findings.

Lingua originale	Inglese
pagine (da-a)	1955-1957
Numero di pagine	3
Rivista	Emerging Microbes and Infections
Volume	9
Numero di pubblicazione	1
DOI	https://doi.org/10.1080/22221751.2020.1814165
Stato di pubblicazione	Pubblicato - 1 gen 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1080/22221751.2020.1814165

Cita questo

@article{6129bb035f2341a38c77a0158d5a723b,

title = "SARS-CoV-2 infection: diagnostic testing results occasionally require special attention",

abstract = "The case refers to a 51-year-old symptomatic man with a new SARS-CoV-2 RNA positive nasopharyngeal swab after two negative ones and the lack of significant development of antibody response measured by different diagnostic serological test. Our case underlines that a discrepancy between clinical course of SARS-CoV-2 infection and results from diagnostic tests may exist. This concept is rapidly emerging and supports the need for a deep knowledge of available and “in development” tests for a correct interpretation of their findings.",

keywords = "SARS-CoV-2 infection, SARS-CoV-2 molecular tests, SARS-CoV-2 serological tests, diagnostic tests, lack of antibodies",

author = "Elisabetta Riva and Sainaghi, \{Pier Paolo\} and Ombretta Turriziani and Guido Antonelli and Giuseppe Patti",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s). Published by Informa UK Limited, trading as Taylor \& Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.",

year = "2020",

month = jan,

day = "1",

doi = "10.1080/22221751.2020.1814165",

language = "English",

volume = "9",

pages = "1955--1957",

journal = "Emerging Microbes and Infections",

issn = "2222-1751",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - SARS-CoV-2 infection

T2 - diagnostic testing results occasionally require special attention

AU - Riva, Elisabetta

AU - Sainaghi, Pier Paolo

AU - Turriziani, Ombretta

AU - Antonelli, Guido

AU - Patti, Giuseppe

PY - 2020/1/1

Y1 - 2020/1/1

N2 - The case refers to a 51-year-old symptomatic man with a new SARS-CoV-2 RNA positive nasopharyngeal swab after two negative ones and the lack of significant development of antibody response measured by different diagnostic serological test. Our case underlines that a discrepancy between clinical course of SARS-CoV-2 infection and results from diagnostic tests may exist. This concept is rapidly emerging and supports the need for a deep knowledge of available and “in development” tests for a correct interpretation of their findings.

AB - The case refers to a 51-year-old symptomatic man with a new SARS-CoV-2 RNA positive nasopharyngeal swab after two negative ones and the lack of significant development of antibody response measured by different diagnostic serological test. Our case underlines that a discrepancy between clinical course of SARS-CoV-2 infection and results from diagnostic tests may exist. This concept is rapidly emerging and supports the need for a deep knowledge of available and “in development” tests for a correct interpretation of their findings.

KW - SARS-CoV-2 infection

KW - SARS-CoV-2 molecular tests

KW - SARS-CoV-2 serological tests

KW - diagnostic tests

KW - lack of antibodies

U2 - 10.1080/22221751.2020.1814165

DO - 10.1080/22221751.2020.1814165

M3 - Letter

SN - 2222-1751

VL - 9

SP - 1955

EP - 1957

JO - Emerging Microbes and Infections

JF - Emerging Microbes and Infections

IS - 1

ER -

SARS-CoV-2 infection: diagnostic testing results occasionally require special attention

Abstract

OSS delle Nazioni Unite

Accesso al documento

Fingerprint

Cita questo